Abstract
The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.
Original language | English (US) |
---|---|
Pages (from-to) | 383-386 |
Number of pages | 4 |
Journal | Therapeutic delivery |
Volume | 1 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2010 |
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science